Edwards received notification from our affiliate in (b)(4).As reported, this was a valve-in-valve case of a 26mm sapien 3 valve implant in a 27mm surgical valve in mitral position by transeptal approach.At the end of the valve deployment the balloon of the commander delivery system burst longitudinally.Despite the balloon burst, the sapien 3 valve was successfully implanted.When retrieving the commander delivery system through the esheath, no issue was found.The commander delivery system was discarded.The patient did not experience any consequences from the event.
|
The device was not returned for evaluation as it was discarded.Therefore, a no product return engineering evaluation was performed.A procedural video was provided, and the following was observed: the balloon burst during balloon inflation at full the end of the thv deployment.The device history record (dhr) review did not reveal any manufacturing nonconformance issues that would have contributed to the event.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint balloon burst was confirmed as per provided procedural video to the unavailability of the complaint device, engineering was unable to perform any visual inspection, functional testing, or dimensional analysis.Therefore, no manufacturing non-conformance was identified during the evaluation.An existing edwards' technical summary has been documented for root cause analysis on balloon bursts in a calcified landing zone.The technical summary provides a rationale as to why it is unlikely that a product defect or manufacturing non-conformance contributed to this type of event, including factors on why deployment of balloons on thv delivery systems are subject to increased risk of burst in a calcified landing zone.As per follow up provided, ''the valve has developed a degree of calcification''.The presence of calcification can create a challenging anatomy for balloon inflation.While the balloons are sufficiently designed and tested for rated burst pressures well above their inflation pressure, calcified nodules can compromise the structure of the balloon wall via following mechanisms such as puncture, local overstretching, open cell impingement, or stress concentration.In addition, the technical summary outlines the extensive manufacturing mitigations in place to prevent this type of malfunction (visual and dimensional inspections, leak testing, and functional balloon burst testing that occurs with every manufactured lot).These inspections and testing further support that it is unlikely that a defect present in manufacturing contributed to the complaint.The technical summary also outlines the instructions for valve deployment.It should be noted that these mitigations are still in place.A review of available information suggests that patient factors (calcification) contributed to the balloon burst.Since no edwards defect was identified, no corrective or preventative action is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
|